Supercomputing-based dimeric analog approach for drug optimization

Parallel Computing

Volumn 24, Issue 9-10, 1998, Pages 1557-1566

  Pang, Yuan Ping ^a   Brimijoin, Stephen ^a  

^a MAYO CLINIC CANCER CENTER   (United States)

Author keywords

Acetylcholinesterase inhibitors; Docking study; Rational drug design; SYSDOC

Indexed keywords

BIOMEDICAL ENGINEERING; DRUG PRODUCTS; OPTIMIZATION; SUBSTRATES;

DRUG OPTIMIZATION; SUPERCOMPUTING-BASED DIMERIC ANALOG APPROACH;

PARALLEL PROCESSING SYSTEMS;

EID: 0032157681     PISSN: 01678191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8191(98)00071-4     Document Type: Article

References (32)

1. I.D. Kuntz, Structure-based strategies for drug design and discovery (Review), Science 257 (1992) 1078.
2. K.S. Lam, M. Lebl, V. Krchnak, The one-bead-one-compound combinatorial library method, Chemical Reviews 97 (1997) 411.
3. B.L. Stoddard, D. Koshland Jr., Molecular recognition analyzed by docking simulations: The aspartate receptor and isocitrate dehydrogenase from Escherichia coli, Proc. Natl. Acad. Sci. USA 90 (1993) 1146.
4. D.A. Dougherty, D.A. Stauffer, Acetylcholine binding by a synthetic receptor: Implications for biological recognition, Science 250 (1990) 1558.
5. S.K. Burley, G.A. Petsko, Aromatic-aromatic interaction: A mechanism of protein structure stabilization (Review) (41 Refs.), Science 229 (1985) 23.
6. C.A. Hunter, J.K.M. Sanders, The nature of pi-pi interactions, J. Am. Chem. Soc. 112 (1990) 5525.
7. Y.-P. Pang, A.P. Kozikowski, Prediction of the binding sites of huperzine a in acetylcholinesterase by docking studies, J. Comput. Aided Mol. Design 8 (1994) 669.
8. Y.-P. Pang, A.P. Kozikowski, Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the sysdoc program, J. Comput. Aided Mol. Design 8 (1994) 683.
9. Y.-P. Pang, P.A. Kollman, Applications of free energy derivatives to analog design, Perspectives in Drug Discovery and Design 3 (1995) 106.
10. D.E. Koshland, The key-lock theory and the induced fit theory (Review), Angewandte Chemie. International Ed. in English 33 (1995) 2375.
11. M.L. Raves, M. Harel, Y.-P. Pang, I. Silman, A.P. Kozikowski, J.L. Sussman, Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine a, Nature Structural Biology 4 (1997) 57.
12. Y.-P. Pang, P. Quiram, T. Jelacic, F. Hong, S. Brimijoin, Highly potent, selective, and low-cost bistetrahydroaminacrine inhibitors of acetylcholinesterase: Steps toward novel drugs for treating Alzheimer's disease, J. Biol. Chem. 271 (1996) 23646.
13. J.-S. Liu, Y.-L. Zhu, C.-M. Yu, Y.-Z. Zhou, Y.-F. Han, F.-W. Wu, B.-F. Qi, The structures of huperzine A and B, two new alkaloids exhibiting marked anticholinesterase activity, Can. J. Chem. 64 (1986) 837.
14. Y.-P. Pang, A.P. Kozikowski, in: C.-G. Wermuth, (Ed.), Trends in QSAR and Molecular Modelling 92, Escom, Leiden, 1993, p. 422.
15. A. Saxena, N.F. Qian, I.M. Kovach, A.P. Kozikowski, Y.-P. Pang, D.C. Vellom, Z. Radic, D. Quinn, P. Taylor, B.P. Doctor, Identification of amino acid residues involved in the binding of huperzine a to cholinesterases, Protein. Sci 3 (1994) 1770.
16. Z. Radic, N.A. Pickering, D.C. Vellom, S. Camp, P. Taylor, Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors, Biochemistry 32 (1993) 12074.
17. J. Eichler, A. Anselment, J.L. Sussman, I. Massoulie, U. Silman, Differential effects of peripheral site ligands on Torpedo and chicken acetylcholinesterase, Mol. Pharmacol 45 (1994) 335.
18. M. Harel, I. Schalk, L. Ehretsabatier, F. Bouet, M. Goeldner, C. Hirth, P.H. Axelsen, I. Silman, J.L. Sussman, Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase, Proc. Natl. Acad. Sci. USA 90 (1993) 9031.
19. M. Pomponi, B. Giardina, F. Gatta, M. Marta, Physostigmines and tetrahydroaminoacridine analogs as alternative drugs for the treatment of Alzheimer's disease, Med. Chem. Res. 2 (1992) 306.
20. H.A. Berman, K. Leonard, Interaction of tetrahydroaminoacridine with acetylcholinesterase and butyrylcholinesterase, Mol. Pharmacol. 41 (1992) 412.
21. J.L. Taylor, R.T. Mayer, C.M. Himel, Conformers of acetylcholinesterase: A mechanism of allosteric control, Mol. Pharmacol. 45 (1994) 74.
22. J.L. Sussman, M. Harel, F. Frolow, C. Oefner, A. Goldman, L. Toker, I. Silman, Atomic structure of acetylcholinesterase from Torpedo californica: A prototypic acetylcholine-binding protein, Science 253 (1991) 872.
23. K.S. Akerfeldt, P.A. Bartlett, Synthesis and evaluation of glucose-ADP hybrids as inhibitors of hexokinase, J. Org. Chem. 56 (1991) 7133.
24. D.E. Koshland, The comparison of non-enzymic and enzymic reaction velocities, J. Theor. Biol. 2 (1962) 75.
25. M. Harel, J.L. Sussman, E. Krejci, S. Bon, P. Chanal, J. Massoulie, I. Silman, Conversion of acetylcholinesterase to butyrylcholinesterase: Modeling and mutagenesis, Proc. Natl. Acad. Sci. USA 89 (1992) 10827.
26. A. Villalobos, T.W. Butler, D.S. Chapin, Y.L. Chen, S.B. Demattos, J.L. Ives, S.B. Jones, D.R. Listen, A.A. Nagel, D.M. Nason, J.A. Nielsen, A.D. Ramirez, I.A. Shalaby, W.F. White, 5,7-dihydro-3-[2-[1-(phenylmethyl)-4-piperidinyl]ethyl]-6h-pyrrolo[3 2-f]-1,2-benzisoxazol-6-one - a potent and centrally-selective inhibitor of acetylcholinesterase with an improved margin of safety, J. Med. Chem. 38 (1995) 2802.
27. G.M. Shutske, F.A. Pierrat, K.J. Kapples, M.L. Cornfeldt, M.R. Szewczak, F.P. Huger, G.M. Bores, V. Haroutunian, K.L. Davis, 9-Amino-1,2,3,4-tetrahydroacridin-1-ols: Synthesis and evaluation as potential Alzheimer's disease therapeutics, J. Med. Chem. 32 (1989) 1805.
28. H. Sugimoto, Y. Iimura, Y. Yamanishi, K. Yamatsu, Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compounds, Bioorg. Med. Chem. Lett. 8 (1992) 871.
29. K.L. Davis, P. Powchik, Tacrine. (Review), Lancet 345 (1995) 625.
30. D.K. Lahiri, S. Lewis, M.R. Farlow, Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines, J. Neuroscience Research 37 (1994) 777.
31. D.K. Lahiri, M.R. Farlow, Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines, J. Molecular Neuroscience 7 (1996) 41.
32. D.K. Lahiri, M.R. Farlow, K. Sambamurti, C. Nail, The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in hela cells, Life Sci. 61 (1997) 1985.